Koers BioSig Technologies Inc Nasdaq
Aandelen
US09073N2018
Geavanceerde medische apparatuur & technologie
Omzet 2024 * | 100K 92,04K | Omzet 2025 * | 1 mln. 920K | Marktkapitalisatie | 19,82 mln. 18,24 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -6 mln. -5,52 mln. | Nettowinst (verlies) 2025 * | -12 mln. -11,04 mln. | EV/omzet 2024 * | 198 x |
Nettoliquiditeiten 2024 * | - 0 | Nettoliquiditeiten 2025 * | - 0 | EV/omzet 2025 * | 19,8 x |
K/w-verhouding 2024 * |
-2,36
x | K/w-verhouding 2025 * |
-1,36
x | Werknemers | - |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 77,81% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Frederick Hrkac
DFI | Director of Finance/CFO | 58 | 27/02 |
Lora Mikolaitis
ADM | Chief Administrative Officer | 51 | 24-02-09 |
Chief Tech/Sci/R&D Officer | 74 | 24-02-09 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Chief Tech/Sci/R&D Officer | 74 | 24-02-09 | |
Frederick Hrkac
DFI | Director of Finance/CFO | 58 | 27/02 |
Steven Abelman
BRD | Director/Board Member | - | 03/05 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+11,91% | 227 mld. | |
+15,46% | 198 mld. | |
+18,58% | 142 mld. | |
+30,36% | 111 mld. | |
+0,34% | 64,16 mld. | |
+17,74% | 54,1 mld. | |
+5,82% | 51,41 mld. | |
+11,23% | 45,32 mld. | |
+5,73% | 37,32 mld. |